The Impact of Market Volatility on the Cell Therapy Industry

被引：20

作者：

Brindley, David A. ^{[1
,2
,3
,7
]}

Reeve, Brock C. ^{[2
]}

Sahlman, William A. ^{[3
]}

Bonfiglio, Greg A. ^{[4
,5
]}

Davie, Natasha L. ^{[1
,2
,6
,7
]}

Culme-Seymour, Emily J. ^{[7
]}

Mason, Chris ^{[1
,7
]}

机构：

[1] UCL, Adv Ctr Biochem Engn, London WC1E 6BT, England

[2] Harvard Stem Cell Inst, Holyoke Ctr, Cambridge, MA 02138 USA

[3] Harvard Univ, Sch Business, Soldiers Field, Boston, MA 02163 USA

[4] Proteus Venture Partners, Portola Valley, CA 94028 USA

[5] Ctr Commercializat Regenerat Med, Toronto, ON M5G 1L5, Canada

[6] Harvard Univ, Sch Med, Ctr Excellence Vasc Biol, Boston, MA 02115 USA

[7] London Regenerat Med Network, London EC1R 0DP, England

来源：

CELL STEM CELL | 2011年 / 9卷 / 05期

关键词：

D O I：

10.1016/j.stem.2011.10.010

中图分类号：

Q813 [细胞工程];

学科分类号：

100113 [医学细胞生物学];

摘要：

引用

页码：397 / 401

页数：5

共 9 条

[1]

Christensen CM, 2000, HARV BUS REV SEP

[2]

Cooksey D., 2006, REV UK HEALTHCARE RE

[3]

Fenn J., 2008, Mastering the Hype Cycle: How to Choose the Right Innovation at the Right Time

[4]

Mason C, 2011, REGEN MED, V6, P265, DOI [10.2217/RME.11.28, 10.2217/rme.11.28]

[5]

Regenerative medicine 2.0 [J].

Mason, Chris .

REGENERATIVE MEDICINE, 2007, 2 (01) :11-18

[6]

Mason C, 2010, REGEN MED, V5, P153, DOI [10.2217/rme.10.14, 10.2217/RME.10.14]

[7]

Pharma's Developing Interest in Stem Cells [J].

McKernan, Ruth ;

McNeish, John ;

Smith, Devyn .

CELL STEM CELL, 2010, 6 (06) :517-520

[8]

Funding Translational Work in Cell-Based Therapy [J].

Rao, Mahendra S. .

CELL STEM CELL, 2011, 9 (01) :7-10

[9]

Sahlman W.A., 1985, Journal of Business Venturing, P7

← 1 →